~Doctor, I Have a Question. What are some of the greatest advances in glaucoma treatment? Question answered by: [caption id="attachment_4257" align="aligncenter" width="152"] Jeffrey M. Liebmann, MD[/caption] As physicians, our goal is to preserve vision and quality of life for all our patients. Our populations are ageing and life expectancy is increasing, which means that there will be more people with
TGF News
A Song for Glaucoma Awareness Month
~A Song for Glaucoma Awareness Month~ “Sometimes art and music can touch people in a way that other things can’t,” says Donna Mulhollan, who together with her husband Kelly are a folk duo from Arkansas who have been touring the U.S, Canada and Europe for 25 years as Still on the Hill. “I am also an artist of sorts and
The Glaucoma Foundation (TGF) Awards $250,000 Grant for Project Forecasting Glaucoma Progression Using Artificial Intelligence
~The Glaucoma Foundation (TGF) Awards $250,000 Grant for Project Forecasting Glaucoma Progression Using Artificial Intelligence~ Newswise — New York, NY, December 31 --The Glaucoma Foundation (TGF) is signing off 2021 with the largest research grant it has ever awarded. Over the years TGF has funded millions of dollars in smaller seed grants for innovative ideas that have led to
TGF 2021 Year In Review
~TGF 2021 Year In Review~ With support from our generous donors over the past year, TGF funded new research projects and brought scientists together from around the world to chart a course for the future. We produced webinars with patients, advocates, physicians, and scientists for thousands of viewers, partnered with Research to Prevent Blindness to award fellowships in glaucoma, and
The TGF (sponsored by Patricia Hill) – RPB Glaucoma Fellowship Winners Announced
The TGF (Sponsored by Patricia Hill) - RPB Glaucoma Fellowship Winners Announced The TGF (sponsored by Patricia Hill) - RPB Glaucoma Fellowship in Glaucoma is a one-year $10,000 supplemental fellowship targeted to under-represented racial and ethnic minorities, as defined by the NIH, who are fellows in Departments of Ophthalmology engaged in substantive glaucoma research. TGF/RPB awarded these fellowships in December
Why is Dry Eye So Prevalent?
Why is Dry Eye So Prevalent? Question answered by: Gregory K. Harmon, MD Chairman, The Glaucoma Foundation Associate Professor of Ophthalmology, Weill Medical College of Cornell University/New York Presbyterian Hospital Dry eye disease is a common eye disorder in which the eyes don’t make enough tears, or the tears evaporate too quickly. It can make your eyes feel dry,
This Giving Tuesday, You Can Do More To Fight Glaucoma
As many of us prepare to gather with family and friends to celebrate Thanksgiving, I want to thank you for being a part of The Glaucoma Foundation’s (TGF) community. Supporters like you help spread the word about our fight against the silent thief of sight. Without the financial support of donors like you, we wouldn’t be able to fund breakthrough
The 27th Annual Optic Nerve Rescue and Restoration Think Tank
The 27th Annual Optic Nerve Rescue and Restoration Think Tank On October 15th, 33 scientists and glaucoma clinicians from research institutions throughout the US and from Canada, Australia, Sweden, Singapore, Hong Kong, Japan, and Germany participated in The Glaucoma Foundation’s 27th Annual Scientific Think Tank, which focused on “New Vistas in Glaucoma Research.” 2021 featured a dynamic hybrid Glaucoma Think Tank
New Horizons in Glaucoma Treatment
Please join us on Wednesday, November 10, 2021 at 5pm Eastern Time on Zoom where Dr. Jeffrey Liebmann will talk about the latest news in glaucoma procedures and treatments. Dr. Jeffrey M. Liebmann graduated from Boston University School of Medicine, completed his ophthalmology residency at the State University of New York/Downstate Medical Center, and his glaucoma fellowship at the New
Uncovering Potential Therapeutic Targets for Glaucoma
[caption id="attachment_3383" align="aligncenter" width="200"] Adriana Di Polo, PhD[/caption] TGF’s new Kumar Mahadeva Research Grant was recently awarded to Dr. Adriana Di Polo, whose lab at the University of Montreal focuses on the pathology of retinal ganglion cells (RGC), the neurons that die in glaucoma. RGCs are metabolically active and require precise regulation of blood supply to meet their high oxygen and nutrient